English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/84101
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders

AuthorsGonzález-Rey, Elena; Delgado, M.
Issue Date2008
CitationMolecular and Cellular Endocrinology 286: 135- 140 (2008)
AbstractIdentification of the factors that regulate the immune tolerance and control the appearance of exacerbated inflammatory conditions is crucial for the development of new therapies of autoimmune diseases. Some neuropeptides and hormones have emerged as endogenous agents that participate in the regulation of the processes that ensure self-tolerance. Among them, cortistatin, an endogenous cyclic neuropeptide relative of somatostatin, has recently shown therapeutic potential for a variety of immune disorders. Here we examine the latest research findings, which indicate that cortistatin participates in maintaining immune tolerance in two distinct ways: by regulating the balance between pro-inflammatory and anti-inflammatory factors, and by inducing the emergence of regulatory T cells with suppressive activity against autoreactive T cell effectors. © 2007 Elsevier Ireland Ltd. All rights reserved.
Identifiersdoi: 10.1016/j.mce.2007.08.001
issn: 0303-7207
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.